Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'syncytium-inducing' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 145 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McDonald, RA; Chang, G; Michael, NL
      Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1

      JOURNAL OF HUMAN VIROLOGY
    2. Grivel, JC; Ito, Y; Faga, G; Santoro, F; Shaheen, F; Malnati, MS; Fitzgerald, W; Lusso, P; Margolis, L
      Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by humanherpesvirus 6

      NATURE MEDICINE
    3. Katzenstein, DA; Hughes, MD; Albrecht, M; Liou, SH; Murphy, R; Balfour, H; Para, M; Hammer, S
      Virologic and CD4 cell response to zidovudine or zidovudine and lamivudinefollowing didanosine treatment of human immunodeficiency virus infection

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    4. Jansson, M; Backstrom, E; Scarlatti, G; Bjorndal, A; Matsuda, S; Rossi, P; Albert, J; Wigzell, H
      Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    5. Ferraro, GA; Mello, MAG; Sutmoller, F; Van Weyenbergh, J; Shindo, N; Galvao-Castro, B; Bou-Habib, DC
      Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    6. ten Haaft, P; Murthy, K; Salas, M; McClure, H; Dubbes, R; Koornstra, W; Niphuis, H; Davis, D; van der Groen, G; Heeney, J
      Differences in early virus loads with different phenotypic variants of HIV-1 and SIVcpz in chimpanzees

      AIDS
    7. Mooij, P; Heeney, JL
      Rational development of prophylactic HIV vaccines based on structural and regulatory proteins

      VACCINE
    8. LaBranche, CC; Galasso, G; Moore, JP; Bolognesi, DP; Hirsch, MS; Hammer, SM
      HIV fusion and its inhibition

      ANTIVIRAL RESEARCH
    9. Resch, W; Hoffman, N; Swanstrom, R
      Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks

      VIROLOGY
    10. Blanco, J; Barretina, J; Cabrera, C; Gutierrez, A; Clotet, B; Este, JA
      CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro

      VIROLOGY
    11. Trouplin, V; Salvatori, F; Cappello, F; Obry, V; Brelot, A; Heveker, N; Alizon, M; Scarlatti, G; Clavel, F; Mammano, F
      Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay

      JOURNAL OF VIROLOGY
    12. Mwinzi, PNM; Karanja, DMS; Colley, DG; Orago, ASS; Secor, WE
      Cellular immune responses of schistosomiasis patients are altered by humanimmunodeficiency virus type 1 coinfection

      JOURNAL OF INFECTIOUS DISEASES
    13. Schacker, T; Little, S; Connick, E; Gebhard, K; Zhang, ZQ; Krieger, J; Pryor, J; Havlir, D; Wong, JK; Schooley, RT; Richman, D; Corey, L; Haase, AT
      Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection

      JOURNAL OF INFECTIOUS DISEASES
    14. Philpott, S; Weiser, B; Anastos, K; Kitchen, CMR; Robison, E; Meyer, WA; Sacks, HS; Mathur-Wagh, U; Brunner, C; Burger, H
      Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy

      JOURNAL OF CLINICAL INVESTIGATION
    15. Pollakis, G; Kang, S; Kliphuis, A; Chalaby, MIM; Goudsmit, J; Paxton, WA
      N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization

      JOURNAL OF BIOLOGICAL CHEMISTRY
    16. Hogan, CM; Hammer, SM
      Host determinants in HIV infection and disease part 1: Cellular and humoral immune responses

      ANNALS OF INTERNAL MEDICINE
    17. Brice, GT; Mayne, AE; Villinger, F; Ansari, AA
      A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4(+) T cells from human and nonhuman primates for distinct coreceptor using lentiviruses

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Ikuta, K; Suzuki, S; Horikoshi, H; Mukai, T; Luftig, RB
      Positive and negative aspects of the human immunodeficiency virus protease: Development of inhibitors versus its role in AIDS pathogenesis

      MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
    19. Oelrichs, RB; Lawson, VA; Coates, KM; Chatfield, C; Deacon, NJ; McPhee, DA
      Rapid full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates

      JOURNAL OF BIOMEDICAL SCIENCE
    20. Wang, WK; Lee, CN; Dudek, T; Chang, SY; Zhao, YJ; Essex, M; Lee, TH
      Interaction between HIV type 1 glycoprotein 120 and CXCR4 coreceptor involves a highly conserved arginine residue in hypervariable region 3

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    21. Katzenstein, DA; Hughes, M; Albrecht, M; Hammer, S; Para, M; Murphy, R; Valdez, H; Haubrich, R; Liou, S
      Virologic and CD4(+) cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    22. Berkowitz, RD; Alexander, S; McCune, JM
      Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    23. Dejucq, N
      HIV-1 replication in CD4(+) T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function

      JOURNAL OF LEUKOCYTE BIOLOGY
    24. Vella, S; Galluzzo, MC; Giannini, G; Pirillo, MF; Andreotti, M; Tomino, C; Fragola, V; Bucciardini, R; Ricciardulli, D; Binelli, A; Weimer, LE; Floridia, M
      Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment

      ANTIVIRAL RESEARCH
    25. Aquino-de Jesus, MJ; Anders, C; Miller, G; Sleasman, JW; Goodenow, MM; Andiman, WA
      Genetically and epidemiologically related "non-syncytium-inducing" isolates of HIV-1 display heterogeneous growth patterns in macrophages

      JOURNAL OF MEDICAL VIROLOGY
    26. Vanham, G; van Tendeloo, V; Willems, B; Penne, L; Kestens, L; Beirnaert, E; Fransen, K; Heyndrickx, L; Zhong, P; Davis, D; Berneman, Z; van der Groen, G; Van Bockstaele, D
      The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells

      JOURNAL OF MEDICAL VIROLOGY
    27. D'Souza, MP; Cairns, JS; Plaeger, SF
      Current evidence and future directions for targeting HIV entry - Therapeutic and prophylactic strategies

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    28. Blaak, H; Ran, LJ; Rientsma, R; Schuitemaker, H
      Susceptibility of in vitro stimulated PBMC to infection with NSIHIV-1 is associated with levels of CCR5 expression and beta-chemokine production

      VIROLOGY
    29. Schramm, B; Penn, ML; Speck, RF; Chan, SY; De Clercq, E; Schols, D; Connor, RI; Goldsmith, MA
      Viral entry through CXCR4 is a pathogenic factor and therapeutic target inhuman immunodeficiency virus type 1 disease

      JOURNAL OF VIROLOGY
    30. Martin, JC; Bandres, JC
      Cells of the monocyte-macrophage lineage and pathogenesis of HIV-1 infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    31. Peeters, M; Vincent, R; Perret, JL; Lasky, M; Patrel, D; Liegeois, F; Courgnaud, V; Seng, R; Matton, T; Molinier, S; Delaporte, E
      Evidence for differences in MT2 cell tropism according to genetic subtypesof HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    32. Stanfield, RL; Cabezas, E; Satterthwait, AC; Stura, EA; Profy, AT; Wilson, IA
      Dual conformations for the HIV-1 gp120 V3 loop in complexes with differentneutralizing Fabs

      STRUCTURE WITH FOLDING & DESIGN
    33. Callaway, DS; Ribeiro, RM; Nowak, MA
      Virus phenotype switching and disease progression in HIV-1 infection

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    34. Andiman, WA
      Association between the biological characteristics of HIV-1, vertical transmission of infection and clinical progression of pediatric disease

      CURRENT OPINION IN INFECTIOUS DISEASES
    35. Verrier, F; Borman, AM; Brand, D; Girard, M
      Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    36. von Briesen, H; Grez, M; Ruppach, H; Raudonat, I; Unger, RE; Becker, K; Panhans, B; Dietrich, U; Rubsamen-Waigmann, H
      Selection of HIV-1 genotypes by cultivation in different primary cells

      AIDS
    37. Young, B; Kuritzkes, DR
      Viral kinetics: implications for treatment

      AIDS
    38. Romano, G; Kasten, M; Giordano, A
      Current understanding of AIDS pathogenesis

      ANTICANCER RESEARCH
    39. McKeating, JA; Balfe, P
      The role of the viral glycoprotein in HIV-1 persistence

      IMMUNOLOGY LETTERS
    40. Bhoopat, L; Patanasakpinyo, C; Yanaranop, M; Bhoopat, T
      Clinico-immunopathological alterations of lymph nodes from human immunodeficiency virus-infected patients in northern Thailand

      ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
    41. Sato, H; Kato, K; Takebe, Y
      Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop

      VIROLOGY
    42. Penn, ML; Grivel, JC; Schramm, B; Goldsmith, MA; Margolis, L
      CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    43. Berkowitz, RD; van't Wout, AB; Kootstra, NA; Moreno, ME; Linquist-Stepps, VD; Bare, C; Stoddart, CA; Schuitemaker, H; McCune, JM
      R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus

      JOURNAL OF VIROLOGY
    44. Ping, LH; Nelson, JAE; Hoffman, IF; Schock, J; Lamers, SL; Goodman, M; Vernazza, P; Kazembe, P; Maida, M; Zimba, D; Goodenow, MM; Eron, JJ; Fiscus, SA; Cohen, MS; Swanstrom, R
      Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants

      JOURNAL OF VIROLOGY
    45. Sato, H; Shiino, T; Kodaka, N; Taniguchi, K; Tomita, Y; Kato, K; Miyakuni, T; Takebe, Y
      Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virustransmission in a single family

      JOURNAL OF VIROLOGY
    46. Shankarappa, R; Margolick, JB; Gange, SJ; Rodrigo, AG; Upchurch, D; Farzadegan, H; Gupta, P; Rinaldo, CR; Learn, GH; He, X; Huang, XL; Mullins, JI
      Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection

      JOURNAL OF VIROLOGY
    47. Giorgi, JV; Hultin, LE; McKeating, JA; Johnson, TD; Owens, B; Jacobson, LP; Shih, R; Lewis, J; Wiley, DJ; Phair, JP; Wolinsky, SM; Detels, R
      Shorter survival in advanced human immunodeficiency virus type 1 infectionis more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage

      JOURNAL OF INFECTIOUS DISEASES
    48. Vandamme, AM; Van Laethem, K; De Clercq, E
      Managing resistance to anti-HIV drugs - An important consideration for effective disease management

      DRUGS
    49. ORLANDI P; CANCRINI C; SCACCIA S; ROMITI ML; LIVADIOTTI S; GATTINARA GC; ANGELINI F; COX S; ROSSI P
      ANALYSIS OF HIV-1 REVERSE-TRANSCRIPTASE GENE-MUTATIONS IN INFECTED CHILDREN TREATED WITH ZIDOVUDINE

      Journal of acquired immune deficiency syndromes and human retrovirology
    50. FAHEY JL
      CYTOKINES, PLASMA IMMUNE ACTIVATION MARKERS, AND CLINICALLY RELEVANT SURROGATE MARKERS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Clinical and diagnostic laboratory immunology
    51. GAO M; TSUCHIE H; JIN TQ; ZHANG J; DETORIO MA; HOSSAIN MM; TANIGUCHI K; KURIMURA T
      DIFFERENCE IN SUSCEPTIBILITY TO CC-CHEMOKINES AMONG HIV-1 ISOLATES

      International journal of STD & AIDS
    52. MEDRANO FJ; LEAL M; ARIENTI D; REY C; ZAGLIANI A; TORRES Y; SANCHEZQUIJANO A; LISSEN E; CLERICI M
      TUMOR-NECROSIS-FACTOR-BETA AND SOLUBLE APO-1 FAS INDEPENDENTLY PREDICT PROGRESSION TO AIDS IN HIV-SEROPOSITIVE PATIENTS/

      AIDS research and human retroviruses
    53. RUCKER J; DOMS RW
      CHEMOKINE RECEPTORS AS HIV CORECEPTORS - IMPLICATIONS AND INTERACTIONS

      AIDS research and human retroviruses
    54. ALBERT JM; IOANNIDIS JPA; REICHELDERFER P; CONWAY B; COOMBS RW; CRANE L; DEMASI R; DIXON DO; FLANDRE P; HUGHES MD; KALISH LA; LARNTZ K; LIN DY; MARSCHNER IC; MUNOZ A; MURRAY J; NEATON J; PETTINELLI C; RIDA W; TAYLOR JMG; WELLES SL
      STATISTICAL ISSUES FOR HIV SURROGATE END-POINTS - POINT COUNTERPOINT/

      Statistics in medicine
    55. BRATT G; LEANDERSSON AC; ALBERT J; SANDSTROM E; WAHREN B
      MT-2 TROPISM AND CCR-5 GENOTYPE STRONGLY INFLUENCE DISEASE PROGRESSION IN HIV-1-INFECTED INDIVIDUALS

      AIDS
    56. BRATT G; KARLSSON A; LEANDERSSON AC; ALBERT J; WAHREN B; SANDSTROM E
      TREATMENT HISTORY AND BASE-LINE VIRAL LOAD, BUT NOT VIRAL TROPISM OR CCR-5 GENOTYPE, INFLUENCE PROLONGED ANTIVIRAL EFFICACY OF HIGHLY-ACTIVE ANTIRETROVIRAL TREATMENT

      AIDS
    57. ROMANO G; MASSI D; GIORDANO A
      THE STANDPOINT OF AIDS RESEARCH AND THERAPY PROGRAMS

      Anticancer research
    58. REICHELDERFER PS; COOMBS RW
      CARTESIAN COORDINATE ANALYSIS OF VIRAL BURDEN AND CD4-CELL COUNT IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION( T)

      Antiviral research
    59. KUPFER B; KAISER R; ROCKSTROH JK; MATZ B; SCHNEWEIS KE
      ROLE OF HIV-1 PHENOTYPE IN VIRAL PATHOGENESIS AND ITS RELATION TO VIRAL LOAD AND CD4-CELL COUNT( T)

      Journal of medical virology
    60. TSCHERNING C; ALAEUS A; FREDRIKSSON R; BJORNDAL A; DENG HK; LITTMAN DR; FENYO EM; ALBERT J
      DIFFERENCES IN CHEMOKINE CORECEPTOR USAGE BETWEEN GENETIC SUBTYPES OFHIV-1

      Virology
    61. FURRER H
      SURROGATE END-POINTS IN CLINICAL-STUDIES, AS EXEMPLIFIED BY HIV-INFECTION

      Schweizerische medizinische Wochenschrift
    62. VALENTIN A; LU WH; ROSATI M; SCHNEIDER R; ALBERT J; KARLSSON A; PAVLAKIS GN
      DUAL EFFECT OF INTERLEUKIN-4 ON HIV-1 EXPRESSION - IMPLICATIONS FOR VIRAL PHENOTYPIC SWITCH AND DISEASE PROGRESSION

      Proceedings of the National Academy of Sciences of the United Statesof America
    63. WILLETT BJ; ADEMA K; HEVEKER N; BRELOT A; PICARD L; ALIZON M; TURNER JD; HOXIE JA; PEIPER S; NEIL JC; HOSIE MJ
      THE 2ND EXTRACELLULAR LOOP OF CXCR4 DETERMINES ITS FUNCTION AS A RECEPTOR FOR FELINE IMMUNODEFICIENCY VIRUS

      Journal of virology
    64. TRKOLA A; KETAS T; KEWALRAMANI VN; ENDORF F; BINLEY JM; KATINGER H; ROBINSON J; LITTMAN DR; MOORE JP
      NEUTRALIZATION SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMARY ISOLATES TO ANTIBODIES AND CD4-BASED REAGENTS IS INDEPENDENT OF CORECEPTOR USAGE

      Journal of virology
    65. GRASSLY NC; XIANG Z; ARIYOSHI K; AABY P; JENSEN H; VANDERLOEFF MS; DIAS F; WHITTLE H; BREUER J
      MORTALITY AMONG HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 2-POSITIVE VILLAGERS IN RURAL GUINEA-BISSAU IS CORRELATED WITH VIRAL GENOTYPE

      Journal of virology
    66. VANTWOUT AB; RAN LJ; KUIKEN CL; KOOTSTRA NA; PALS ST; SCHUITEMAKER H
      ANALYSIS OF THE TEMPORAL RELATIONSHIP BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 QUASI-SPECIES IN SEQUENTIAL BLOOD-SAMPLES AND VARIOUS ORGANS OBTAINED AT AUTOPSY

      Journal of virology
    67. DRUSANO GL; BILELLO JA; STEIN DS; NESSLY M; MEIBOHM A; EMINI EA; DEUTSCH P; CONDRA J; CHODAKEWITZ J; HOLDER DJ
      FACTORS INFLUENCING THE EMERGENCE OF RESISTANCE TO INDINAVIR - ROLE OF VIROLOGICAL, IMMUNOLOGICAL, AND PHARMACOLOGICAL VARIABLES

      The Journal of infectious diseases
    68. YU XF; WANG Z; VLAHOV D; MARKHAM RB; FARZADEGAN H; MARGOLICK JB
      INFECTION WITH DUAL-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ASSOCIATED WITH RAPID TOTAL T-CELL DECLINE AND DISEASE PROGRESSION IN INJECTION-DRUG USERS

      The Journal of infectious diseases
    69. VIANI RM; SMITH IL; SPECTOR SA
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPES IN CHILDREN WITH ADVANCED DISEASE TREATED WITH LONG-TERM ZALCITABINE

      The Journal of infectious diseases
    70. LATHEY JL; HUGHES MD; FISCUS SA; PI T; JACKSON JB; RASHEED S; ELBEIK T; REICHMAN R; JAPOUR A; DAQUILA RT; SCOTT W; GRIFFITH BP; HAMMER SM; KATZENSTEIN DA
      VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/

      The Journal of infectious diseases
    71. FISCUS SA; HUGHES MD; LATHEY JL; PI T; JACKSON JB; RASHEED S; ELBEIK T; REICHMAN R; JAPOUR A; BYINGTON R; SCOTT W; GRIFFITH BP; KATZENSTEIN DA; HAMMER SM
      CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES

      The Journal of infectious diseases
    72. Torres, Y; Medrano, FJ; Rey, C; Calderon, EJ; Sanchez-Quijano, A; Lissen, E; Leal, M
      Evidence for a role of T-helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium-inducing phenotype

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    73. MOYLE GJ; GAZZARD BG; COOPER DA; GATELL J
      ANTIRETROVIRAL THERAPY FOR HIV-INFECTION - A KNOWLEDGE-BASED APPROACHTO DRUG SELECTION AND USE

      Drugs
    74. BROWN AJL; RICHMAN DD
      HIV-1 - GAMBLING ON THE EVOLUTION OF DRUG-RESISTANCE

      Nature medicine
    75. SCARLATTI G; TRESOLDI E; BJORNDAL A; FREDRIKSSON R; COLOGNESI C; DENG HK; MALNATI MS; PLEBANI A; SICCARDI AG; LITTMAN DR; FENYO EM; LUSSO P
      IN-VIVO EVOLUTION OF HIV-1 CORECEPTOR USAGE AND SENSITIVITY TO CHEMOKINE-MEDIATED SUPPRESSION

      Nature medicine
    76. NORRGREN H; MARQUINA S; LEITNER T; AABY P; MELBYE M; POULSEN AG; LARSEN O; DIAS F; ESCANILLA D; ANDERSSON S; ALBERT J; NAUCLER A
      HIV-2 GENETIC-VARIATION AND DNA LOAD IN ASYMPTOMATIC CARRIERS AND AIDS CASES IN GUINEA-BISSAU

      Journal of acquired immune deficiency syndromes and human retrovirology
    77. OPERSKALSKI EA; BUSCH MP; MOSLEY JW; STRAM DO
      COMPARATIVE RATES OF DISEASE PROGRESSION AMONG PERSONS INFECTED WITH THE SAME OR DIFFERENT HIV-1 STRAINS

      Journal of acquired immune deficiency syndromes and human retrovirology
    78. MILDVAN D; LANDAY A; DEGRUTTOLA V; MACHADO SG; KAGAN J
      AN APPROACH TO THE VALIDATION OF MARKERS FOR USE IN AIDS CLINICAL-TRIALS

      Clinical infectious diseases
    79. SINICCO A; FORA R; RAITERI R; SCIANDRA M; BECHIS G; CALVO MM; GIOANNINI P
      IS THE CLINICAL COURSE OF HIV-1 CHANGING - COHORT STUDY

      BMJ. British medical journal
    80. MELLADO MJ; CILLERUELO MJ; ORTIZ M; VILLOTA J; GARCIA M; PEREZJURADO ML; BARREIRO G; MARTINFONTELOS P; BERNAL A
      VIRAL PHENOTYPE, ANTIRETROVIRAL RESISTANCE AND CLINICAL EVOLUTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN

      The Pediatric infectious disease journal
    81. CHEN MS; SINGH MK; BALACHANDRAN R; GUPTA P
      ISOLATION AND CHARACTERIZATION OF 2 DIVERGENT INFECTIOUS MOLECULAR CLONES OF HIV TYPE-1 LONGITUDINALLY OBTAINED FROM A SEROPOSITIVE PATIENTBY A PROGRESSIVE AMPLIFICATION PROCEDURE

      AIDS research and human retroviruses
    82. OLIVARES I; SHAW G; LOPEZGALINDEZ C
      PHENOTYPIC SWITCH IN A SPANISH HIV TYPE-1 ISOLATE ON SERIAL PASSAGE ON MT-4 CELLS

      AIDS research and human retroviruses
    83. MEYAARD L; MIEDEMA F
      IMMUNE DYSREGULATION AND CD4(-CELL LOSS IN HIV-1 INFECTION() T)

      Perspectives in mathematical logic
    84. MOYLE GJ
      CURRENT KNOWLEDGE OF HIV-1 REVERSE-TRANSCRIPTASE MUTATIONS SELECTED DURING NUCLEOSIDE ANALOG THERAPY - THE POTENTIAL TO USE RESISTANCE DATATO GUIDE CLINICAL DECISIONS

      Journal of antimicrobial chemotherapy
    85. ANDERSON R; BARRESINOUSSI F; BRADAC J; BURKE DS; ESSEX M; FENYO EM; GALVAOCASTRO B; HU DJ; JAFFE H; KARAMOV E; KUIKEN C; KUNANUSONT C; LAGA M; LOWER J; MASTRO T; MCCUTCHAN FE; OPIO A; PAULI G; SUTHERLAND D; SCHWARTLANDER B; DEVINCENZI I; VONBRIESEN H; WASI C; WEBER J; PIOT P; CARAEL M; OSMANOV S
      IMPLICATIONS OF HIV VARIABILITY FOR TRANSMISSION - SCIENTIFIC AND POLICY ISSUES

      AIDS
    86. ASJO B; BARIN F; BIBERFELD G; BRADAC J; BUVE A; DIELLY S; FONTANET A; GURTLER L; VANDERGROEN G; HOELSCHER M; HOLMHANSEN C; HU D; JORDANHARDER B; KALEEBU P; KAPTUE L; KORBER B; LEVIN A; LUKASHOV V; LYAMUYA E; MBOUP S; MCCUTCHAN FE; JACKSON HM; MHALU F; MKWERA H; MSOBI N; MULLINS J; MWAKAGILE D; NANDI J; NKENGASONG J; NUKULILA T; OSMANOV S; PEETERS M; PLETSCHETTE M; SCARLATTI G; SHAO J; SHAO YM; SONNENBURG FV; SUTHERLAND D; TENNAGASHAW M; URASSA W; DEVINCENZI I; WEBER J; WILLIAMSON C; WOLF H
      HIV-1 SUBTYPES - IMPLICATIONS FOR EPIDEMIOLOGY, PATHOGENICITY, VACCINES AND DIAGNOSTICS - WORKSHOP REPORT FROM THE EUROPEAN-COMMISSION (DG-XII, INCO-DC) AND THE JOINT UNITED-NATIONS PROGRAM ON HIV AIDS/

      AIDS
    87. BALOTTA C; BAGNARELLI P; VIOLIN M; RIDOLFO AL; ZHOU D; BERLUSCONI A; CORVASCE S; CORBELLINO M; CLEMENTI M; CLERICI M; MORONI M; GALLI M
      HOMOZYGOUS DELTA-32 DELETION OF THE CCR-5 CHEMOKINE RECEPTOR GENE IN AN HIV-1-INFECTED PATIENT

      AIDS
    88. ERCOLI L; SARMATI L; NICASTRI E; GIANNINI G; GALLUZZO C; VELLA S; ANDREONI M
      HIV PHENOTYPE SWITCHING DURING ANTIRETROVIRAL THERAPY - EMERGENCE OF SAQUINAVIR-RESISTANT STRAINS WITH LESS CYTOPATHOGENICITY

      AIDS
    89. LIESNARD C; DELFORGE ML; TCHETCHEROFF M; DEMAERTELAER V; FARBER CM; VANVOOREN JP
      IMPORTANCE OF METHOD IN THE DETERMINATION OF SYNCYTIUM-INDUCING PHENOTYPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLINICAL ISOLATES

      Journal of virological methods
    90. ALMULLA W; CHURCH D; GILL MJ
      PHENOTYPIC VARIATIONS AND SWITCHES IN HIV ISOLATED FROM THE BLOOD ANDTHE GASTROINTESTINAL TISSUES OF PATIENTS WITH HIV-1 INFECTION

      Journal of medical virology
    91. JOLLY PE
      REPLICATIVE CHARACTERISTICS OF PRIMARY ISOLATES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, PRIMARY MACROPHAGES AND CD4-CELL LINES( TRANSFORMED T)

      Cellular and molecular biology
    92. COHEN OJ; KINTER A; FAUCI AS
      HOST FACTORS IN THE PATHOGENESIS OF HIV-DISEASE

      Immunological reviews
    93. MILICH L; MARGOLIN BH; SWANSTROM R
      PATTERNS OF AMINO-ACID VARIABILITY IN NSI-LIKE AND SI-LIKE V3 SEQUENCES AND A LINKED CHANGE IN THE CD4-BINDING DOMAIN OF THE HIV-I ENV PROTEIN

      Virology
    94. SPECK RF; WEHRLY K; PLATT EJ; ATCHISON RE; CHARO IF; KABAT D; CHESEBRO B; GOLDSMITH MA
      SELECTIVE EMPLOYMENT OF CHEMOKINE RECEPTORS AS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CORECEPTORS DETERMINED BY INDIVIDUAL AMINO-ACIDS WITHIN THE ENVELOPE V3 LOOP

      Journal of virology
    95. SHIODA T; OKA S; XIN XM; LIU HL; HARUKUNI R; KUROTANI A; FUKUSHIMA M; HASAN MK; SHINO T; TAKEBE Y; IWAMOTO A; NAGAI Y
      IN-VIVO SEQUENCE VARIABILITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GP120 - ASSOCIATION OF V2 EXTENSION WITH SLOW DISEASE PROGRESSION

      Journal of virology
    96. LIU SL; SCHACKER T; MUSEY L; SHRINER D; MCELRATH MJ; COREY L; MULLINS JI
      DIVERGENT PATTERNS OF PROGRESSION TO AIDS AFTER INFECTION FROM THE SAME SOURCE - HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EVOLUTION AND ANTIVIRAL RESPONSES

      Journal of virology
    97. NELSON JAE; FISCUS SA; SWANSTROM R
      EVOLUTIONARY VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 REGION CHARACTERIZED BY USING A HETERODUPLEX TRACKING ASSAY

      Journal of virology
    98. GOEPFERT PA; SHAW KL; RITTER GD; MULLIGAN MJ
      A SORTING MOTIF LOCALIZES THE FOAMY VIRUS GLYCOPROTEIN TO THE ENDOPLASMIC-RETICULUM

      Journal of virology
    99. STEIN DS; LYLES RH; GRAHAM NMH; TASSONI CJ; MARGOLICK JB; PHAIR JP; RINALDO C; DETELS R; SAAH A; BILELLO J
      PREDICTING CLINICAL PROGRESSION OR DEATH IN SUBJECTS WITH EARLY-STAGEHUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION - A COMPARATIVE-ANALYSISOF QUANTIFICATION OF HIV RNA, SOLUBLE TUMOR-NECROSIS-FACTOR TYPE-II RECEPTORS, NEOPTERIN, AND BETA(2)-MICROGLOBULIN

      The Journal of infectious diseases
    100. PAL A; GREENOUGH TC; SULLIVAN JL; SOMASUNDARAN M
      IN-VITRO CHARACTERIZATION OF ADULT PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - DEMONSTRATION OF DISTINCTIVE SINGLE-CELL KILLING PHENOTYPES IN SPITE OF SIMILAR LEVELS OF VIRAL REPLICATION

      The Journal of infectious diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 22:23:54